#1272
Telotristat Etiprate Appears to Halt Carcinoid Heart Disease
Introduction:
Carcinoid Heart Disease (CHD) is a serious complication of the Carcinoid Syndrome (in as many as 50% of patients during the course of their disease). 46% of cases operated with bioprosthetic valves develop recurrent carcinoid valvulopathy on the newly implanted tissue valves. Until now, only mechanical prosthetic valves avoid recurrent fibrosis.
Conference:
13th Annual ENETSConcerence (2016)
Presenting Author:
Zacks J
Authors:
Zacks J,
Lavine R,
Ratner L,
Warner R,
Keywords:
carcinoid heart disease,
valve,
heart failure,
carcinoid syndrome,
prosthetic valves,
telotristat etiprate,
#261
Recognizing Carcinoid Heart Disease and Timing of Cardiac and Abdominal Procedures
Introduction:
Recognition of right heart failure in Carcinoid Heart Disease enables a decision to be made concerning the proper timing of Cardiac and abdominal tumor-reductive surgery.
Conference:
8th Annual ENETSConcerence (2011)
Presenting Author:
Authors:
Zacks J,
Shafir M,
Castillo J,
Choi J,
Warner R,
Keywords:
carcinoid heart disease,
valve surgery,
right heart failure,
abdominal carcinoid,
neuroendocrine ,